Dang Shen for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Dang Shen for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A mild, inexpensive root used as food and tonic, with a broad but shallow evidence base. Almost none of a swallowed dose is absorbed, so any effect likely runs through gut bacteria. Measured benefits come from multi-herb formulas in disease states. Harms look modest at customary amounts; plausible interactions with clotting, blood sugar and immune-suppressing medication matter more. (Full Review)

Protocol

Standard practitioner protocol
9 to 30 g dried root daily
As a decoction, most often 9 to 15 g, given inside a formula rather than alone, over courses of four to twelve weeks
Alternative approach, Western herbal practice
1:5 tincture, 3 to 5 mL, two or three times daily
Or standardized extracts at 500 to 1,500 mg daily, treating the root as a single agent
Best time of day
Morning and early afternoon
With or just before food; evening dosing is avoided because difficulty sleeping appeared among pooled adverse events
Time to effect
Reduced chemotherapy toxicity
4 to 12 weeks
Chemotherapy-support studies ran courses comparable to the lung-function trials
Lung function and exercise capacity
4 to 12 weeks
Lung-function and quality-of-life trials measured change at four to twelve weeks
Onset overall
Weeks, not days
Nothing in the literature reports an acute effect

Benefits

Contraindications
  • Pregnancy and lactation, at any stage
  • Solid-organ transplant recipients on calcineurin inhibitors, indefinitely after transplantation
  • Active immunosuppressive therapy for autoimmune disease, including biologics and prednisone above 7.5 mg daily
  • Immunosuppressants (tacrolimus, ciclosporin, azathioprine, mycophenolate)
  • Surgery, dental extraction or biopsy scheduled within 14 days
  • Bleeding disorders or a platelet count below 100 × 109/L
  • Known allergy to bellflower-family plants
  • Men on abiraterone or other androgen-receptor-directed therapy for prostate cancer
    •
Key Interactions
  • Anticoagulants and antiplatelet drugs (warfarin, apixaban, clopidogrel, low-dose aspirin)
  • Antidiabetic drugs (metformin, glipizide, insulin)
  • Antihypertensives (lisinopril, amlodipine, bisoprolol)
  • Over-the-counter medication (ibuprofen, naproxen, aspirin, sulfite-containing remedies)
  • Supplement interactions (ginkgo, fish oil, high-dose vitamin E, garlic, nattokinase)
  • Supplements with additive effects (astragalus, Panax ginseng, echinacea, medicinal mushrooms)
  • Supplements with additive glucose lowering (berberine, cinnamon extract, chromium, bitter melon)
  • Other intervention interactions (chemotherapy, Veratrum nigrum, checkpoint immunotherapy)
    •

Risk & Side Effects

  • High:
  • Medium: Gastrointestinal upset, dry mouth, and insomnia
    •
  • Low: High-dose chest discomfort, dizziness, and confusion; hypersensitivity reactions with injectable preparations; sulfur-fumigation residues and altered root chemistry; increased bleeding tendency; blood-sugar lowering
  • Speculative: Opposition to immunosuppressive therapy; reduced effect of androgen-blocking cancer drugs

Monitoring

Marker Target Why
Fasting glucose 75–86 mg/dL Catches the root's glucose-lowering effect
Hemoglobin A1c 4.8–5.2% Confirms a sustained rather than one-off glucose shift
Seated blood pressure 110–120 / 70–80 mmHg Alkaloids lower blood pressure in animals
Absolute neutrophil count 1.8–4.0 × 109/L Tracks the white-cell claim and any marrow effect
Platelet count 175–350 × 109/L Screens the reported slowing of clotting
High-sensitivity C-reactive protein Below 0.5 mg/L Tracks the anti-inflammatory claim
Alanine aminotransferase 10–26 U/L (men), 10–19 U/L (women) Detects liver strain from a daily botanical
Estimated glomerular filtration rate Above 90 mL/min/1.73 m2 Confirms kidney handling stays intact

Cadence: Baseline, then glucose, blood pressure and blood count repeated at four weeks and twelve weeks, then every six to twelve months while use continues; weekly for the first month alongside glucose-lowering or clotting-slowing medication.

Qualitative Assessment

  • Energy through the mid-afternoon rather than at a single peak
  • Appetite before meals and comfort in the two hours after them
  • Stool form and frequency, the classic marker of the state the root is used for
  • Time to fall asleep, the earliest sign that dosing has drifted too late in the day
  • Breathlessness climbing one flight of stairs, where lung function is the goal
  • Recovery from a hard training session over 24 to 48 hours
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.